It is imperative that pathogenic variants in the PNPT1 gene be considered in clinical practice for the proper diagnostic work-up of patients with early-onset spastic ataxia or spastic paraparesis that is associated with optic atrophy, regardless of the presence of a significant neurological family history. This evidence concerns the gene PNPT1 and spastic ataxia.